Drug Use and Addiction Research Programs in Washington
Drug Use and Addiction Research Programs (93.279) awarded $235 million to recipients in Washington in 173 grants from fiscal 2021 to 2025, 3.2% of the program's national total. University of Washington received the most, $143 million.
- Awarded in Washington$235 million
- Awards173
- Share of the program3.2%
- Rank among states10th of 50
- National total$7.3 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 71 | $33.4 million |
| FY 2022 | 79 | $51.6 million |
| FY 2023 | 88 | $49.0 million |
| FY 2024 | 88 | $45.3 million |
| FY 2025 | 81 | $55.9 million |
Recipients in Washington
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Washington | Colleges and universities | 120 | $143 million |
| Allen Institute | Nonprofits | 4 | $31.9 million |
| Seattle Children's Hospital | Nonprofits | 9 | $16.3 million |
| Fred Hutchinson Cancer Center | Nonprofits | 7 | $11.2 million |
| Washington State University | Colleges and universities | 16 | $9.2 million |
| Omeros Corporation | Small businesses | 1 | $6.7 million |
| Achieve Life Sciences, Inc. | Small businesses | 2 | $2.8 million |
| Evidence-Based Practice Institute, Inc. | Small businesses | 1 | $2.8 million |
| Ayuda Medical, LLC | Small businesses | 1 | $2.5 million |
| 2MORROW Inc | Small businesses | 2 | $2.1 million |
Open opportunities under this program
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)
- Emerging Global Leader Award (K43 Independent Clinical Trial Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Intervention Research to Improve Native American Health (R34 Clinical Trial Optional)
See all 109 on the program page
Questions people ask
How much Drug Use and Addiction Research Programs money goes to Washington?
$235 million from fiscal 2021 to 2025, across 173 awards. Washington ranks 10th of 50 states and territories for this program.
Who receives Drug Use and Addiction Research Programs money in Washington?
The largest recipient is University of Washington, with $143 million in 120 awards. Next are Allen Institute and Seattle Children's Hospital.
Can organizations in Washington apply now?
Yes, 109 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Drug Use and Addiction Research Programs in other states
Other large programs in Washington
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Federal Transit Formula Grants
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- National School Lunch Program
- Federal Transit Capital Investment Grants
- Allergy and Infectious Diseases Research
- Child Care and Development Block Grant